2921 - 2930 of 7939 Results
Title
Year
-
OPENTitle: Folded concave penalized learning of high-dimensional MRI data in Parkinson’s diseaseJournal Name: Journal of Neuroscience MethodsPublisher: Elsevier BVVol: 357Issue #:Start Page: 109157End Page: 109157Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.jneumeth.2021.109157Best OA location URL: http://manuscript.elsevier.com/S0165027021000923/pdf/S0165027021000923.pdfCitation Count: 1
-
RESTRICTEDTitle: Parkinson's diseaseJournal Name: The LancetPublisher: Elsevier BVVol: 397Issue #: 10291Start Page: 2284End Page: 2303Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s0140-6736(21)00218-xBest OA location URL: https://repository.ubn.ru.nl//bitstream/handle/2066/235670/235670.pdfCitation Count: 1391
-
OPENTitle: Proceedings of Reanimation 2021, the French Intensive Care Society International CongressJournal Name: Annals of Intensive CarePublisher: Springer Science and Business Media LLCVol: 11Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13613-021-00862-0Best OA location URL: https://annalsofintensivecare.springeropen.com/track/pdf/10.1186/s13613-021-00862-0Citation Count: 7
- Safety and Tolerability of Active Immunotherapy Targeting α-Synuclein with PD03A in Patients with Early Parkinson’s Disease: A Randomized, Placebo-Controlled, Phase 1 Study2021OPENTitle: Safety and Tolerability of Active Immunotherapy Targeting α-Synuclein with PD03A in Patients with Early Parkinson’s Disease: A Randomized, Placebo-Controlled, Phase 1 StudyJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 3Start Page: 1079End Page: 1089Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212594Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212594?id=journal-of-parkinsons-disease%2Fjpd212594Citation Count: 42
-
RESTRICTEDTitle: The emerging landscape of single-molecule protein sequencing technologiesJournal Name: Nature MethodsPublisher: Springer Science and Business Media LLCVol: 18Issue #: 6Start Page: 604End Page: 617Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41592-021-01143-1Best OA location URL: https://www.nature.com/articles/s41592-021-01143-1.pdfCitation Count: 204
-
OPENTitle: The Records of the Human Sciences Research CouncilJournal Name: History in AfricaPublisher: Cambridge University Press (CUP)Vol: 48Issue #:Start Page: 397End Page: 411Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1017/hia.2021.15Citation Count: 1
- Alzheimer's disease research progress in Australia: The Alzheimer's Association International Conference Satellite Symposium in Sydney2021RESTRICTEDTitle: Alzheimer's disease research progress in Australia: The Alzheimer's Association International Conference Satellite Symposium in SydneyJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 18Issue #: 1Start Page: 178End Page: 190Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.12380Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.12380Citation Count: 6
- Comparative pharmacovigilance assessment of mortality with pimavanserin in Parkinson disease-related psychosis2021OPENTitle: Comparative pharmacovigilance assessment of mortality with pimavanserin in Parkinson disease-related psychosisJournal Name: Journal of Managed Care & Specialty PharmacyPublisher: Academy of Managed Care PharmacyVol: 27Issue #: 6Start Page: 785End Page: 790Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.18553/jmcp.2021.27.6.785Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391001Citation Count: 8
- Development and evaluation of [18F]Flotaza for Aβ plaque imaging in postmortem human Alzheimer’s disease brain2021OPENTitle: Development and evaluation of [18F]Flotaza for Aβ plaque imaging in postmortem human Alzheimer’s disease brainJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 46Issue #:Start Page: 128164End Page: 128164Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2021.128164Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379902Citation Count: 13
-
OPENTitle: Thyroarytenoid Muscle Gene Expression in a Rat Model of Early‐Onset Parkinson's DiseaseJournal Name: The LaryngoscopePublisher: WileyVol: 131Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/lary.29661Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8595495Citation Count: 10